Serum inflammatory factors such as MMP-9 are associated with post-percutaneous transluminal angioplastyacute myocardial infarction in coronary heart disease patients complicated by lower extremity arteriosclerosis obliterans.
Shao C, Wuren B, Chi G, Ren H, Li F, Song W, Wang B, Ding M.
Cell Mol Biol (Noisy-le-grand). 2023 Dec 31;69(15):38-43. doi: 10.14715/cmb/2023.69.15.6.
PMID:38279498
Coronary artery vasomotion after percutaneous transluminal coronary angioplasty.
Ambulatory electrocardiography evaluation of the post-coronary artery bypass graft and post-percutaneous transluminal coronary angioplasty patient. Diagnostic and prognostic value.
Droste C, Roskamm H.
Cardiol Clin. 1992 Aug;10(3):431-48.
PMID:1504974
Comparative effectiveness and safety of prasugrel and ticagrelor in patients of acute coronary syndrome undergoing percutaneous transluminal coronary angioplasty: A propensity score-matched analysis.
Ray A, Najmi A, Khandelwal G, Jhaj R, Sadasivam B.
Indian Heart J. 2024 Mar-Apr;76(2):133-135. doi: 10.1016/j.ihj.2024.03.001. Epub 2024 Mar 13.
PMID:38485052
Rosuvastatin-Induced Myopathy: A Case Series.
Malani SK, Chigullapalli S, Sujanyal S, Sharma V.
Cureus. 2024 Aug 5;16(8):e66180. doi: 10.7759/cureus.66180. eCollection 2024 Aug.
PMID:39233949
FDG PET/CT in Dressler Syndrome.
Taywade S, Gupta T, Kumar R, Choudhary R, Kumar D.